PL3337487T3 - Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania - Google Patents
Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowaniaInfo
- Publication number
- PL3337487T3 PL3337487T3 PL16836765T PL16836765T PL3337487T3 PL 3337487 T3 PL3337487 T3 PL 3337487T3 PL 16836765 T PL16836765 T PL 16836765T PL 16836765 T PL16836765 T PL 16836765T PL 3337487 T3 PL3337487 T3 PL 3337487T3
- Authority
- PL
- Poland
- Prior art keywords
- honocol
- magnolol
- formulations
- application
- increased stability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Anesthesiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2534DE2015 | 2015-08-17 | ||
| PCT/IN2016/050021 WO2017029683A1 (en) | 2015-08-17 | 2016-01-18 | Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof |
| EP16836765.4A EP3337487B1 (en) | 2015-08-17 | 2016-01-18 | Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3337487T3 true PL3337487T3 (pl) | 2021-12-06 |
Family
ID=58051448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16836765T PL3337487T3 (pl) | 2015-08-17 | 2016-01-18 | Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10328090B2 (pl) |
| EP (1) | EP3337487B1 (pl) |
| JP (1) | JP6663993B2 (pl) |
| KR (1) | KR20180050331A (pl) |
| AU (2) | AU2016308080A1 (pl) |
| CA (1) | CA2995834A1 (pl) |
| DK (1) | DK3337487T3 (pl) |
| ES (1) | ES2873601T3 (pl) |
| HU (1) | HUE054161T2 (pl) |
| PL (1) | PL3337487T3 (pl) |
| PT (1) | PT3337487T (pl) |
| WO (1) | WO2017029683A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3769174B1 (en) | 2018-03-21 | 2022-07-06 | Realtime Robotics, Inc. | Motion planning of a robot for various environments and tasks and improved operation of same |
| KR20200083304A (ko) * | 2018-12-28 | 2020-07-08 | 충북대학교 산학협력단 | 일본 목련 추출물을 유효성분으로 함유하는 불안장애의 예방 또는 치료용 약학적 조성물 |
| US20220015406A1 (en) * | 2019-01-25 | 2022-01-20 | Flaask, Llc | Compositions and Methods for Improving Quality of Life in Patients with Autism Spectrum Disorder |
| CN110585140A (zh) * | 2019-07-08 | 2019-12-20 | 苏州海特比奥生物技术有限公司 | 一种和厚朴酚纳米聚合物胶束冻干制剂及其制备方法 |
| US12213505B2 (en) * | 2021-07-05 | 2025-02-04 | Healthy Ingredient Solutions, LLC | Composition for promoting restful sleep and methods of making and using the same |
| WO2025136962A1 (en) * | 2023-12-19 | 2025-06-26 | Rebalance Health, Inc. | Compositions for reducing hot flashes and symptoms associated with anxiety and formulations thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582735B2 (en) | 2000-12-15 | 2003-06-24 | Npi, Llc. | Compositions and methods of use for extracts of magnoliaceae plants |
| CN1723011A (zh) | 2002-06-25 | 2006-01-18 | Wm·雷格利Jr·公司 | 含有厚朴提取物的口气清新和口腔清洁产品 |
| US7632525B2 (en) | 2002-06-25 | 2009-12-15 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents |
| RU2396941C2 (ru) | 2005-12-02 | 2010-08-20 | Джи Ай Си ИННОВАТИОНЗ КОМПАНИ | Наполнители с экстрактом коры магнолии для ухода за полостью рта |
| US7544377B2 (en) | 2005-12-02 | 2009-06-09 | Gic Innovations Company | Chewable compositions with fast release magnolia bark extract |
| WO2007064505A1 (en) | 2005-12-02 | 2007-06-07 | Gic Innovations Company | Confectionary compositions with magnolia bark extract |
| KR101527829B1 (ko) | 2007-04-19 | 2015-06-12 | 마리 케이 인코포레이티드 | 마그놀리아 추출물 함유 조성물 |
| WO2011115476A1 (en) | 2010-03-17 | 2011-09-22 | N.V. Nutricia | Infant nutrition for improving fatty acid composition of brain membranes later in life |
| DE102010015791A1 (de) * | 2010-04-20 | 2011-10-20 | Beiersdorf Ag | Wirkstoffkombinationen aus Magnolienrindenextrakt und polyethoxylierten Verbindungen |
| DE102010015792A1 (de) * | 2010-04-20 | 2011-10-20 | Beiersdorf Ag | Wirkstoffkombinationen aus Magnolienrindenextrakt und oberflächenaktiven Agentien |
| RU2606841C2 (ru) * | 2010-09-03 | 2017-01-10 | Н.В. Нютрисиа | Способ и препарат для лечения или профилактики тревожности или нейрогенеза |
| FR2970294B1 (fr) * | 2011-01-11 | 2012-12-28 | Peugeot Citroen Automobiles Sa | Ligne d'echappement pour un moteur a combustion interne |
| IE20110008A1 (en) | 2011-01-12 | 2012-08-01 | Patrick Thomas Prendergast | Compositions for alleviating:- stress, anxiety, depression and aiding with weight loss |
| WO2013043151A1 (en) * | 2011-09-19 | 2013-03-28 | Framroze Bomi P | Edible oil with a high concentration of poly-unsaturated fatty acids |
| EP2759065B8 (en) * | 2011-09-20 | 2023-05-03 | VivaQuant, Inc. | Physiological signal denoising |
-
2016
- 2016-01-18 KR KR1020187007412A patent/KR20180050331A/ko not_active Ceased
- 2016-01-18 PT PT168367654T patent/PT3337487T/pt unknown
- 2016-01-18 PL PL16836765T patent/PL3337487T3/pl unknown
- 2016-01-18 ES ES16836765T patent/ES2873601T3/es active Active
- 2016-01-18 HU HUE16836765A patent/HUE054161T2/hu unknown
- 2016-01-18 CA CA2995834A patent/CA2995834A1/en not_active Abandoned
- 2016-01-18 DK DK16836765.4T patent/DK3337487T3/da active
- 2016-01-18 AU AU2016308080A patent/AU2016308080A1/en not_active Abandoned
- 2016-01-18 WO PCT/IN2016/050021 patent/WO2017029683A1/en not_active Ceased
- 2016-01-18 EP EP16836765.4A patent/EP3337487B1/en active Active
- 2016-01-18 JP JP2018528109A patent/JP6663993B2/ja not_active Expired - Fee Related
- 2016-01-18 US US15/319,887 patent/US10328090B2/en active Active
-
2022
- 2022-02-24 AU AU2022201271A patent/AU2022201271A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018528266A (ja) | 2018-09-27 |
| JP6663993B2 (ja) | 2020-03-13 |
| ES2873601T3 (es) | 2021-11-03 |
| KR20180050331A (ko) | 2018-05-14 |
| AU2016308080A1 (en) | 2018-03-22 |
| AU2022201271A1 (en) | 2022-03-17 |
| HUE054161T2 (hu) | 2021-08-30 |
| EP3337487A4 (en) | 2019-04-03 |
| CA2995834A1 (en) | 2017-02-23 |
| US20180147220A1 (en) | 2018-05-31 |
| EP3337487A1 (en) | 2018-06-27 |
| EP3337487B1 (en) | 2021-02-24 |
| PT3337487T (pt) | 2021-05-27 |
| DK3337487T3 (da) | 2021-05-25 |
| US10328090B2 (en) | 2019-06-25 |
| WO2017029683A1 (en) | 2017-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| IL257531A (en) | Therapeutic combinations comprising anti-folr1 immunoconjugates | |
| EP3337502A4 (en) | STABLE ANTI-IFNAR1 FORMULATION | |
| PT3355990T (pt) | Compostos semifluorados e as suas composições | |
| PL3265448T3 (pl) | Proleki riluzolu i ich zastosowanie | |
| HUE066955T2 (hu) | Nedvszívó struktúra | |
| EP3065716C0 (en) | FORMULATIONS | |
| BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
| SI4070787T1 (sl) | Farmacevtske formulacije | |
| IL256322A (en) | Improved formulations of deferasirox and methods of making the same | |
| EP3328353A4 (en) | TOPICAL SKIN FORMULATIONS | |
| DK3310340T3 (da) | Formulering med høj koncentration | |
| EP3435953A4 (en) | COSMETIC MATERIAL COMPOSITIONS | |
| EP3364945C0 (en) | SOLID FORMULATION | |
| EP3395325A4 (en) | LIQUID COSMETIC COMPOSITION | |
| PT3261437T (pt) | Compostos e composições fungicidas | |
| IL258966A (en) | Absorbent structure | |
| EP3318245A4 (en) | UV-REJECTING COSMETIC COMPOSITION | |
| BR112016027379A2 (pt) | formulações tópicas e seus usos | |
| PL3337487T3 (pl) | Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania | |
| EP3551291A4 (en) | COMPOSITION OF DRY SHAMPOO | |
| DK3288640T3 (da) | Tørshampoosammensætning | |
| IL264445A (en) | Compounds and compositions and uses thereof | |
| EP3328354A4 (en) | TOPICAL SKIN FORMULATIONS | |
| DK3316856T3 (da) | Blandede formuleringer |